The prevalence of nonalcoholic fatty liver disease in the Americas
Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 2
Abstract
Nonalcoholic fatty liver disease (NAFLD) is an alarming public health problem. The disease is one of the main causes of chronic liver disease worldwide and is directly linked to the increased prevalence of obesity and type 2 diabetes mellitus (T2DM) in the general population. The worldwide prevalence of NAFLD has been estimated at 20-30%, but the prevalence is unknown in the Americas because of a lack of epidemiological studies. However, given the trends in the prevalence of diabetes and obesity, the prevalence of NAFLD and its consequences are expected to increase in the near future. The aim of the present study is to present the current data on the prevalence of NAFLD in the Americas. We performed an electronic search of the main databases from January 2000 to September 2013 and identified 356 reports that were reviewed. We focused on the epidemiology and prevalence of known NAFLD risk factors including obesity, T2DM, and the metabolic syndrome (MS). The prevalence of the MS was highest in the United States, Mexico, Costa Rica, Puerto Rico, Chile, and Venezuela. In addition, Puerto Rico, Guyana, and Mexico have the highest prevalence of T2DM in the Americas, while USA has the most people with T2DM. In conclusion, the prevalence rates of NAFLD and obesity were highest in the United States, Belize, Barbados, and Mexico.
Authors and Affiliations
Jorge A. López-Velázquez, Karen V. Silva-Vidal, Guadalupe Ponciano-Rodríguez, Norberto C. Chávez-Tapia, Marco Arrese, Misael Uribe, Nahum Méndez-Sánchez
Keywords
Related Articles
- EP ID EP78372
- DOI -
- Views 113
- Downloads 0
Transjugular intrahepatic portosystemic shunt is associated with significant changes in mitral inflow parameters
[b]Introduction[/b]. Liver cirrhosis is associated with hyperdynamic circulation which can result in heart failure. Transjugular intrahepatic portosystemic shunt (TIPS) due to increase of cardiac output is a stressful st...
Methimazole-induced hypothyroidism causes alteration of the REDOX environment, oxidative stress, and hepatic damage; events not caused by hypothyroidism itself
Our objective was to compare, over a time-course, markers of oxidative stress, the REDOX environment, and the antioxidant enzymatic system in the liver of rats with methimazole- or thyroidectomy-caused hypothyroidism. Me...
A giant hepatic hemangioma treated successfully with hepatic enucleation
Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and the third leading cause of cancer related death worldwide. In recent years, the prevalence of HCC has increased in both developing and d...
Andres Blei (Andy) October 1949-October 2008